Kura Oncology Inc. Daily Stock Analysis

Daily Stock Analysis, KURA, Kura Oncology Inc, priceseries

Kura Oncology Inc. Daily Stock Analysis
Stock Information
Open
15.39
Close
16.20
High
16.31
Low
15.37
Previous Close
15.42
Daily Price Gain
0.78
YTD High
16.70
YTD High Date
Mar 2, 2022
YTD Low
11.49
YTD Low Date
Jan 24, 2022
YTD Price Change
1.51
YTD Gain
10.28%
52 Week High
32.33
52 Week High Date
Mar 10, 2021
52 Week Low
11.49
52 Week Low Date
Jan 24, 2022
52 Week Price Change
-14.05
52 Week Gain
-46.45%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Dec 9. 2016
5.45
Dec 30. 2016
5.90
13 Trading Days
8.20%
Link
LONG
Feb 27. 2017
7.60
Mar 6. 2017
8.20
5 Trading Days
7.89%
Link
LONG
Apr 6. 2017
9.20
Apr 28. 2017
10.19
15 Trading Days
10.80%
Link
LONG
Aug 3. 2017
9.50
Aug 8. 2017
10.32
3 Trading Days
8.68%
Link
LONG
Sep 8. 2017
11.80
Sep 11. 2017
12.62
1 Trading Days
6.99%
Link
LONG
Dec 20. 2017
14.30
Jan 4. 2018
15.29
9 Trading Days
6.96%
Link
LONG
Jan 11. 2018
15.65
Feb 5. 2018
18.72
16 Trading Days
19.60%
Link
LONG
Feb 15. 2018
21.05
Mar 8. 2018
22.47
14 Trading Days
6.75%
Link
LONG
Jun 29. 2018
18.20
Jul 23. 2018
20.03
15 Trading Days
10.04%
Link
LONG
Nov 28. 2018
12.32
Dec 17. 2018
13.15
12 Trading Days
6.73%
Link
LONG
Jan 4. 2019
15.15
Jan 17. 2019
16.02
9 Trading Days
5.73%
Link
LONG
Apr 8. 2020
8.99
May 13. 2020
14.50
24 Trading Days
61.30%
Link
LONG
May 15. 2020
15.30
Jun 3. 2020
16.63
12 Trading Days
8.72%
Link
LONG
Aug 4. 2020
17.16
Sep 4. 2020
23.15
23 Trading Days
34.93%
Link
LONG
Sep 8. 2020
25.59
Sep 23. 2020
28.45
11 Trading Days
11.16%
Link
LONG
Sep 24. 2020
28.80
Oct 20. 2020
32.41
18 Trading Days
12.53%
Link
LONG
Nov 5. 2020
34.92
Nov 18. 2020
37.27
9 Trading Days
6.74%
Link
LONG
Dec 4. 2020
36.80
Dec 7. 2020
39.81
1 Trading Days
8.18%
Link
LONG
Dec 8. 2020
38.86
Dec 9. 2020
40.93
1 Trading Days
5.33%
Link
LONG
Dec 15. 2021
13.17
Dec 29. 2021
14.80
9 Trading Days
12.41%
Link
LONG
Jan 24. 2022
12.90
Jan 27. 2022
13.62
3 Trading Days
5.54%
Link
Company Information
Stock Symbol
KURA
Exchange
NasdaqGS
Company URL
http://www.kuraoncology.com
Company Phone
(858) 500-8800
CEO
Troy E. Wilson
Headquarters
California
Business Address
3033 SCIENCE PARK ROAD, SUITE 220, SAN DIEGO, CA 92121
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001422143
About

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia; KO-947 which is an ERK inhibitor for MAPK Pathway Tumors; and KO-539 which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in La Jolla, CA.

Description

Developing in-licensed protein inhibitors for solid tumors and blood cancers.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading